(+)-schisandrin B multiple interactions ISO RGD:2011 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ACADL mRNA] CTD PMID:31150632 (R)-lipoic acid multiple interactions ISO RGD:2011 6480464 Thioctic Acid inhibits the reaction [Dietary Fats results in decreased expression of ACADL mRNA] CTD PMID:22464149 1,2-dimethylhydrazine decreases expression EXP 6480464 1, 2-Dimethylhydrazine results in decreased expression of ACADL mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions EXP 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ACADL mRNA CTD PMID:22206623 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of ACADL mRNA CTD PMID:17942748 17beta-estradiol multiple interactions ISO RGD:2011 6480464 [Estradiol co-treated with Testosterone] results in increased expression of ACADL mRNA CTD PMID:11375906 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of ACADL mRNA CTD PMID:19484750 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:733759 6480464 Dihydrotestosterone results in increased expression of ACADL mRNA CTD PMID:29581250 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:733759 6480464 Tetrachlorodibenzodioxin results in decreased expression of ACADL mRNA CTD PMID:20106945 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:2011 6480464 Tetrachlorodibenzodioxin affects the expression of ACADL mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:733759 6480464 Tetrachlorodibenzodioxin results in increased expression of ACADL mRNA CTD PMID:21296121 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to ACADL promoter] CTD PMID:19654925 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:2011 6480464 Tetrachlorodibenzodioxin results in decreased expression of ACADL mRNA CTD PMID:11752688 3,3',4,4'-tetrachlorobiphenyl multiple interactions EXP 6480464 3 more ... CTD PMID:19467301 5-fluorouracil increases expression ISO RGD:733759 6480464 Fluorouracil results in increased expression of ACADL protein CTD PMID:15585135 , PMID:16803524 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole affects expression ISO RGD:2011 6480464 Omeprazole affects the expression of ACADL mRNA CTD PMID:19483382 6-propyl-2-thiouracil affects expression ISO RGD:2011 6480464 Propylthiouracil affects the expression of ACADL mRNA CTD PMID:19483382 acetamide decreases expression ISO RGD:2011 6480464 acetamide results in decreased expression of ACADL mRNA CTD PMID:31881176 aflatoxin B1 decreases methylation ISO RGD:733759 6480464 Aflatoxin B1 results in decreased methylation of ACADL gene CTD PMID:27153756 amiodarone affects expression ISO RGD:2011 6480464 Amiodarone affects the expression of ACADL mRNA CTD PMID:19483382 ammonium chloride affects expression ISO RGD:2011 6480464 Ammonium Chloride affects the expression of ACADL mRNA CTD PMID:16483693 aniline increases nitrosation ISO RGD:2011 6480464 aniline results in increased nitrosation of ACADL protein CTD PMID:21708182 aripiprazole decreases expression ISO RGD:2011 6480464 Aripiprazole results in decreased expression of ACADL mRNA CTD PMID:17868501 Aroclor 1254 decreases expression EXP 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of ACADL mRNA CTD PMID:25270620 arsenite(3-) decreases expression EXP 6480464 arsenite results in decreased expression of ACADL mRNA CTD PMID:33053406 benzbromarone affects expression ISO RGD:2011 6480464 Benzbromarone affects the expression of ACADL mRNA CTD PMID:19483382 benzo[a]pyrene multiple interactions EXP 6480464 AHR protein affects the reaction [Benzo(a)pyrene affects the expression of ACADL mRNA] CTD PMID:22228805 benzo[a]pyrene affects methylation ISO RGD:733759 6480464 Benzo(a)pyrene affects the methylation of ACADL promoter CTD PMID:27901495 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of ACADL mRNA CTD PMID:22228805 beta-hexachlorocyclohexane decreases expression EXP 6480464 beta-hexachlorocyclohexane results in decreased expression of ACADL mRNA, beta-hexachlorocyclohexane results in decreased expression of ACADL protein CTD PMID:28397872 bezafibrate multiple interactions EXP 6480464 PPARA protein affects the reaction [Bezafibrate results in increased expression of ACADL mRNA], PPARA protein affects the reaction [Bezafibrate results in increased expression of ACADL protein] CTD PMID:12782154 bezafibrate increases expression EXP 6480464 Bezafibrate results in increased expression of ACADL mRNA, Bezafibrate results in increased expression of ACADL protein CTD PMID:12782154 bis(2-ethylhexyl) phthalate increases expression EXP 6480464 Diethylhexyl Phthalate results in increased expression of ACADL mRNA CTD PMID:19850644 bis(2-ethylhexyl) phthalate increases expression ISO RGD:2011 6480464 Diethylhexyl Phthalate results in increased expression of ACADL mRNA CTD PMID:22672789 bis(2-ethylhexyl) phthalate multiple interactions EXP 6480464 PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of ACADL mRNA] CTD PMID:19850644 bisphenol A increases expression ISO RGD:2011 6480464 bisphenol A results in increased expression of ACADL mRNA CTD PMID:25181051 bisphenol A decreases expression ISO RGD:2011 6480464 bisphenol A results in decreased expression of ACADL mRNA CTD PMID:34947998 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of ACADL mRNA CTD PMID:33221593 bisphenol A decreases expression ISO RGD:733759 6480464 bisphenol A analog results in decreased expression of ACADL mRNA, bisphenol A results in decreased expression of ACADL mRNA CTD PMID:32763284 bisphenol F increases expression ISO RGD:733759 6480464 4, 4'-bisphenol F results in increased expression of ACADL mRNA CTD PMID:32763284 cadmium atom increases oxidation EXP 6480464 Cadmium results in increased oxidation of ACADL protein CTD PMID:24496640 carbon nanotube increases expression EXP 6480464 Nanotubes more ... CTD PMID:25620056 choline multiple interactions EXP 6480464 [Choline deficiency co-treated with Methionine deficiency] results in increased expression of ACADL mRNA CTD PMID:25178843 clofibrate multiple interactions EXP 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of ACADL mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ACADL mRNA] CTD PMID:17585979 clofibrate increases expression EXP 6480464 Clofibrate results in increased expression of ACADL mRNA CTD PMID:17585979 more ... clofibrate increases expression ISO RGD:2011 6480464 Clofibrate results in increased expression of ACADL mRNA, Clofibrate results in increased expression of ACADL protein CTD PMID:12851107 more ... clofibrate affects expression ISO RGD:2011 6480464 Clofibrate affects the expression of ACADL mRNA CTD PMID:19483382 copper atom multiple interactions ISO RGD:2011 6480464 [Fructose co-treated with Copper deficiency] results in decreased expression of ACADL mRNA CTD PMID:25813056 copper(0) multiple interactions ISO RGD:2011 6480464 [Fructose co-treated with Copper deficiency] results in decreased expression of ACADL mRNA CTD PMID:25813056 cyclosporin A decreases expression ISO RGD:2011 6480464 Cyclosporine results in decreased expression of ACADL mRNA CTD PMID:19224547 cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of ACADL mRNA CTD PMID:23830897 cyclosporin A decreases expression ISO RGD:733759 6480464 Cyclosporine results in decreased expression of ACADL mRNA CTD PMID:20106945 more ... dexamethasone decreases expression EXP 6480464 Dexamethasone results in decreased expression of ACADL protein CTD PMID:33567340 Di-n-hexyl phthalate decreases expression ISO RGD:733759 6480464 di-n-hexyl phthalate results in decreased expression of ACADL mRNA CTD PMID:33043605 dibutyl phthalate increases expression ISO RGD:2011 6480464 Dibutyl Phthalate results in increased expression of ACADL mRNA CTD PMID:21266533 dichloroacetic acid increases expression EXP 6480464 Dichloroacetic Acid results in increased expression of ACADL mRNA CTD PMID:23575800 , PMID:28962523 diuron increases expression ISO RGD:2011 6480464 Diuron results in increased expression of ACADL mRNA CTD PMID:21551480 dorsomorphin multiple interactions ISO RGD:733759 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACADL mRNA CTD PMID:27188386 doxorubicin multiple interactions EXP 6480464 [Doxorubicin co-treated with MT2A protein] results in decreased expression of ACADL protein, sodium nitrate inhibits the reaction [Doxorubicin results in increased expression of ACADL protein] CTD PMID:16144979 , PMID:21251210 doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of ACADL mRNA, Doxorubicin results in increased expression of ACADL protein CTD PMID:21251210 , PMID:31768571 doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of ACADL mRNA, Doxorubicin results in decreased expression of ACADL protein CTD PMID:16144979 , PMID:26873546 ethanol multiple interactions EXP 6480464 [Ethanol co-treated with Zinc] results in increased expression of ACADL mRNA CTD PMID:19637192 ethanol affects splicing EXP 6480464 Ethanol affects the splicing of ACADL mRNA CTD PMID:30319688 ethanol increases expression EXP 6480464 Ethanol results in increased expression of ACADL mRNA CTD PMID:30319688 fenamidone increases expression EXP 6480464 fenamidone results in increased expression of ACADL mRNA CTD PMID:27029645 fenofibrate increases expression EXP 6480464 Fenofibrate results in increased expression of ACADL mRNA CTD PMID:17690133 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of ACADL mRNA CTD PMID:17702527 flutamide increases expression ISO RGD:2011 6480464 Flutamide results in increased expression of ACADL protein CTD PMID:17311803 folic acid multiple interactions EXP 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ACADL mRNA CTD PMID:22206623 folic acid decreases expression EXP 6480464 Folic Acid results in decreased expression of ACADL mRNA CTD PMID:25629700 fructose multiple interactions ISO RGD:2011 6480464 [Fructose co-treated with Copper deficiency] results in decreased expression of ACADL mRNA CTD PMID:25813056 furan affects binding ISO RGD:2011 6480464 furan binds to ACADL protein CTD PMID:22240984 GW 4064 multiple interactions ISO RGD:733759 6480464 [GW 4064 co-treated with Oleic Acid] results in decreased expression of ACADL mRNA CTD PMID:30611723 GW 4064 decreases expression ISO RGD:733759 6480464 GW 4064 results in decreased expression of ACADL mRNA CTD PMID:30611723 GW 7647 multiple interactions ISO RGD:733759 6480464 [GW 7647 co-treated with Oleic Acid] results in decreased expression of ACADL mRNA CTD PMID:30611723 isoprenaline multiple interactions ISO RGD:2011 6480464 [Isoproterenol co-treated with POSTN protein] results in decreased expression of ACADL mRNA more ... CTD PMID:25045214 , PMID:30303030 isoprenaline decreases expression ISO RGD:2011 6480464 Isoproterenol results in decreased expression of ACADL mRNA CTD PMID:25045214 ivermectin decreases expression ISO RGD:733759 6480464 Ivermectin results in decreased expression of ACADL protein CTD PMID:32959892 L-ethionine affects expression ISO RGD:2011 6480464 Ethionine affects the expression of ACADL mRNA CTD PMID:19483382 L-methionine multiple interactions EXP 6480464 [Choline deficiency co-treated with Methionine deficiency] results in increased expression of ACADL mRNA CTD PMID:25178843 lead(0) decreases expression ISO RGD:733759 6480464 Lead results in decreased expression of ACADL mRNA CTD PMID:19921347 lead(2+) decreases expression ISO RGD:733759 6480464 Lead results in decreased expression of ACADL mRNA CTD PMID:19921347 lipoic acid multiple interactions ISO RGD:2011 6480464 Thioctic Acid inhibits the reaction [Dietary Fats results in decreased expression of ACADL mRNA] CTD PMID:22464149 meldonium increases expression EXP 6480464 3-(2 more ... CTD PMID:32389661 methapyrilene decreases expression ISO RGD:2011 6480464 Methapyrilene results in decreased expression of ACADL mRNA CTD PMID:16393664 microcystin-LR decreases expression EXP 6480464 cyanoginosin LR results in decreased expression of ACADL protein CTD PMID:26984711 monosodium L-glutamate multiple interactions EXP 6480464 [Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of ACADL mRNA CTD PMID:19001666 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine decreases expression ISO RGD:733759 6480464 N more ... CTD PMID:19637192 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine multiple interactions ISO RGD:733759 6480464 Zinc inhibits the reaction [N more ... CTD PMID:19637192 N-ethyl-N-nitrosourea increases expression ISO RGD:2011 6480464 Ethylnitrosourea results in increased expression of ACADL mRNA CTD PMID:15954086 N-nitrosodiethylamine decreases expression ISO RGD:2011 6480464 Diethylnitrosamine results in decreased expression of ACADL mRNA CTD PMID:11323195 N-nitrosomorpholine decreases expression ISO RGD:2011 6480464 N-nitrosomorpholine results in decreased expression of ACADL protein CTD PMID:19716841 nickel atom decreases expression ISO RGD:733759 6480464 Nickel results in decreased expression of ACADL mRNA CTD PMID:24768652 , PMID:25583101 nitrofen increases expression ISO RGD:2011 6480464 nitrofen results in increased expression of ACADL mRNA CTD PMID:33484710 oleic acid multiple interactions ISO RGD:733759 6480464 [GW 4064 co-treated with Oleic Acid] results in decreased expression of ACADL mRNA, [GW 7647 co-treated with Oleic Acid] results in decreased expression of ACADL mRNA CTD PMID:30611723 omeprazole affects expression ISO RGD:2011 6480464 Omeprazole affects the expression of ACADL mRNA CTD PMID:19483382 paclitaxel decreases expression ISO RGD:733759 6480464 Paclitaxel results in decreased expression of ACADL protein CTD PMID:15907983 paracetamol multiple interactions EXP 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of ACADL mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ACADL mRNA] CTD PMID:17585979 paracetamol decreases expression ISO RGD:733759 6480464 Acetaminophen results in decreased expression of ACADL mRNA CTD PMID:29067470 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of ACADL protein CTD PMID:21329376 paracetamol affects expression ISO RGD:2011 6480464 Acetaminophen affects the expression of ACADL protein CTD PMID:16687475 paraquat affects expression ISO RGD:2011 6480464 Paraquat affects the expression of ACADL mRNA CTD PMID:18198484 perfluorohexanesulfonic acid increases expression EXP 6480464 perfluorohexanesulfonic acid results in increased expression of ACADL mRNA CTD PMID:28558994 perfluorononanoic acid increases expression EXP 6480464 perfluoro-n-nonanoic acid results in increased expression of ACADL mRNA CTD PMID:28558994 perfluorooctane-1-sulfonic acid increases expression ISO RGD:2011 6480464 perfluorooctane sulfonic acid results in increased expression of ACADL mRNA CTD PMID:18692542 perfluorooctane-1-sulfonic acid increases expression EXP 6480464 perfluorooctane sulfonic acid results in increased expression of ACADL mRNA CTD PMID:19429403 more ... perfluorooctanoic acid increases expression ISO RGD:2011 6480464 perfluorooctanoic acid results in increased expression of ACADL mRNA CTD PMID:19162173 perfluorooctanoic acid multiple interactions EXP 6480464 [perfluorooctanoic acid co-treated with Dietary Fats, Unsaturated] results in increased expression of ACADL mRNA CTD PMID:23626681 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of ACADL mRNA CTD PMID:17681415 more ... perfluorooctanoic acid affects expression EXP 6480464 perfluorooctanoic acid affects the expression of ACADL mRNA CTD PMID:18281256 , PMID:19429403 phenobarbital affects expression ISO RGD:733759 6480464 Phenobarbital affects the expression of ACADL mRNA CTD PMID:19159669 phenylmercury acetate increases expression ISO RGD:733759 6480464 Phenylmercuric Acetate results in increased expression of ACADL mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:733759 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACADL mRNA CTD PMID:27188386 phlorizin decreases expression EXP 6480464 Phlorhizin results in decreased expression of ACADL mRNA CTD PMID:22538082 pirinixic acid multiple interactions EXP 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of ACADL mRNA more ... CTD PMID:17950772 more ... pirinixic acid increases expression ISO RGD:2011 6480464 pirinixic acid results in increased expression of ACADL mRNA CTD PMID:19162173 more ... pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of ACADL mRNA CTD PMID:15375163 more ... pirinixic acid affects expression ISO RGD:2011 6480464 pirinixic acid affects the expression of ACADL mRNA CTD PMID:19483382 progesterone increases expression ISO RGD:2011 6480464 Progesterone results in increased expression of ACADL mRNA CTD PMID:20726854 resveratrol increases expression EXP 6480464 resveratrol results in increased expression of ACADL protein CTD PMID:25505154 rotenone increases expression ISO RGD:2011 6480464 Rotenone results in increased expression of ACADL protein CTD PMID:35544339 SB 431542 multiple interactions ISO RGD:733759 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACADL mRNA CTD PMID:27188386 sirolimus multiple interactions ISO RGD:2011 6480464 Sirolimus inhibits the reaction [Isoproterenol results in decreased expression of ACADL mRNA], TNF protein inhibits the reaction [Sirolimus inhibits the reaction [Isoproterenol results in decreased expression of ACADL mRNA]] CTD PMID:25045214 sodium dichromate increases expression ISO RGD:2011 6480464 sodium bichromate results in increased expression of ACADL mRNA CTD PMID:12325037 sodium fluoride decreases expression EXP 6480464 Sodium Fluoride results in decreased expression of ACADL protein CTD PMID:28918527 sodium nitrate multiple interactions EXP 6480464 sodium nitrate inhibits the reaction [Doxorubicin results in increased expression of ACADL protein] CTD PMID:21251210 sulforaphane increases expression EXP 6480464 sulforaphane results in increased expression of ACADL mRNA CTD PMID:30529165 sunitinib decreases expression ISO RGD:733759 6480464 Sunitinib results in decreased expression of ACADL mRNA CTD PMID:31533062 tacrolimus hydrate decreases expression EXP 6480464 Tacrolimus results in decreased expression of ACADL mRNA CTD PMID:25270620 Tesaglitazar increases expression ISO RGD:2011 6480464 tesaglitazar results in increased expression of ACADL mRNA CTD PMID:21515302 testosterone multiple interactions ISO RGD:2011 6480464 [Estradiol co-treated with Testosterone] results in increased expression of ACADL mRNA CTD PMID:11375906 tetrachloroethene increases expression EXP 6480464 Tetrachloroethylene results in increased expression of ACADL mRNA CTD PMID:28973375 tetrachloromethane decreases expression ISO RGD:2011 6480464 Carbon Tetrachloride results in decreased expression of ACADL mRNA CTD PMID:31150632 tetrachloromethane multiple interactions ISO RGD:2011 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ACADL mRNA] CTD PMID:31150632 tetracycline multiple interactions EXP 6480464 bicyclol inhibits the reaction [Tetracycline results in decreased expression of ACADL mRNA] CTD PMID:19427351 tetracycline decreases expression EXP 6480464 Tetracycline results in decreased expression of ACADL mRNA CTD PMID:19427351 thioacetamide affects expression ISO RGD:2011 6480464 Thioacetamide affects the expression of ACADL mRNA CTD PMID:19483382 thioacetamide decreases expression ISO RGD:2011 6480464 Thioacetamide results in decreased expression of ACADL mRNA CTD PMID:34492290 tributylstannane increases expression EXP 6480464 tributyltin results in increased expression of ACADL mRNA CTD PMID:23428407 trichloroacetic acid increases expression EXP 6480464 Trichloroacetic Acid results in increased expression of ACADL mRNA CTD PMID:23575800 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of ACADL mRNA CTD PMID:23575800 , PMID:28973375 triclosan decreases expression ISO RGD:733759 6480464 Triclosan results in decreased expression of ACADL mRNA CTD PMID:30510588 troglitazone increases expression ISO RGD:2011 6480464 troglitazone results in increased expression of ACADL protein CTD PMID:21315101 valproic acid decreases expression ISO RGD:733759 6480464 Valproic Acid results in decreased expression of ACADL mRNA, Valproic Acid results in decreased expression of ACADL protein CTD PMID:29154799 , PMID:29501571 zinc atom multiple interactions ISO RGD:733759 6480464 Zinc inhibits the reaction [N more ... CTD PMID:19637192 zinc atom multiple interactions EXP 6480464 [Ethanol co-treated with Zinc] results in increased expression of ACADL mRNA CTD PMID:19637192 zinc(0) multiple interactions ISO RGD:733759 6480464 Zinc inhibits the reaction [N more ... CTD PMID:19637192 zinc(0) multiple interactions EXP 6480464 [Ethanol co-treated with Zinc] results in increased expression of ACADL mRNA CTD PMID:19637192 zoledronic acid decreases expression EXP 6480464 zoledronic acid results in decreased expression of ACADL mRNA CTD PMID:28871336
